๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Gastric Cancer (GC)

Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05) NCT07165847Phase 21 site๐Ÿ“ Chongqing Daping Hospital and the Research Institute of Surgery of thโ€ฆ ยท Tests: Iparomlimab and Tuvonralimab, Oxaliplatin, Tegafur, Radiotherapy Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer NCT07313579n/a1 site๐Ÿ“ Kyiv Ukrainian Society of Clinical Oncology ยท Tests: curative-intent surgery + HIPEC Iparomlimab and Tuvonralimab (QL1706) Combined With Chemotherapy for Previously Untreated Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer NCT07315854Phase 21 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Iparomlimab and Tuvonralimab (QL1706), SOX Chemotherapy A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites๐Ÿ“ Maumee๐Ÿ“ Portland๐Ÿ“ Fairfax TwoStep Therapeutics, Inc. ยท Tests: TS-104 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites๐Ÿ“ Phoenix๐Ÿ“ Scottsdale๐Ÿ“ Duarte Seagen, a wholly owned subsidiary of Pfizer ยท Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) TEAS Timing for Gastrectomy Recovery (TEAS-TIME Trial) NCT07714980NA13 sites๐Ÿ“ Dongying๐Ÿ“ Qingdao๐Ÿ“ Qingdao The Affiliated Hospital of Qingdao University ยท Tests: Transcutaneous Electrical Acupoint Stimulation, Sham Transcutaneous Electrical Acupoint Stimulation TEAS for Gastrectomy Recovery NCT07898293NA8 sites๐Ÿ“ Qingdao๐Ÿ“ Qingdao๐Ÿ“ Qingdao The Affiliated Hospital of Qingdao University ยท Tests: Transcutaneous Electrical Acupoint Stimulation, Transcutaneous Electrical Acupoint Stimulation A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma NCT07069712Phase 270 sites๐Ÿ“ Newark๐Ÿ“ Washington D.C.๐Ÿ“ Fairway AstraZeneca ยท Tests: Sonesitatug Vedotin, Rilvegostomig, Trastuzumab Deruxtecan (T-DXd), Capecitabine, 5-Fluorouracil (5-FU) THE-0504 in Patients With Solid Tumors NCT07646106Phase 11 site๐Ÿ“ Rome Thena Biotech S.r.l. ยท Tests: THE-0504 A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor NCT05262491Phase 16 sites๐Ÿ“ Beijing๐Ÿ“ Nanchang๐Ÿ“ Jinan Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B01D1 Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) NCT07401199n/a9 sites๐Ÿ“ Fuyang๐Ÿ“ Cangzhou๐Ÿ“ Hengshui Qun Zhao ยท Tests: Standard of Care PD-1 Inhibitors, Multimodal AI Assessment A Study of MGC030 in Participants With Advanced Solid Tumors NCT07822399Phase 11 site๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC030 Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ Patients NCT06650332Phase 1, Phase 21 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: cadonilimab, Trastuzumab, XELOX, Disitamab Vedotin, mFOLFOX6 A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors NCT07070232Phase 1, Phase 277 sites๐Ÿ“ Phoenix๐Ÿ“ San Francisco๐Ÿ“ Hartford BioNTech SE ยท Tests: BNT326, Pumitamig, Itraconazole, Paroxetine Validating a Medical AI Fine-Tuning Platform for Major Diseases NCT07795645n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Smart Medical Big Data Dataset Construction, Large-Scale Medical Knowledge Graph Construction, Multi-Disease Medical Laโ€ฆ Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer NCT07689851Phase 23 sites๐Ÿ“ Shenzhen๐Ÿ“ Taiyuan๐Ÿ“ Beijing Cancer Institute and Hospital, Chinese Academy of Medical Sโ€ฆ ยท Tests: COPOX, Radiotherapy, SHR-1701 Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer๏ผšMetBio-GC NCT07076979n/a1 site๐Ÿ“ Shanghai Shanghai Minimally Invasive Surgery Center A Study of SH009 Injection in Patients With Advanced Solid Tumors. NCT07390838Phase 11 site๐Ÿ“ Shanghai Nanjing Sanhome Pharmaceutical, Co., Ltd. ยท Tests: SH009 The Prevalence and the Pathophysiological Role of Non-Helicobacter Pylori Helicobacter Spp. in Well-defined Gastric Diseases and (Pre-) Malignancies NCT07770126n/a3 sites๐Ÿ“ Edegem๐Ÿ“ Ghent๐Ÿ“ Kortrijk Universiteit Antwerpen Comparison of Double-tract and Tubular Gastric Anastomosis in Proximal Gastric Cancer NCT07635836NA1 site๐Ÿ“ Jinan Qilu Hospital of Shandong University ยท Tests: Double-tract reconstruction SHR-1701 + Rivoceranib (ยฑ SHR-2554) in Advanced GC After First-Line Immunotherapy Failure NCT07311408Phase 21 site๐Ÿ“ Shenyang Jingdong Zhang ยท Tests: SHR-1701+Rivoceranib + SHR-2554, SHR-1701 + Rivoceranib The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric Cancer NCT07183150n/a1 site๐Ÿ“ Tianjin Tianjin Medical University Cancer Institute and Hospital PPG vs. ICG in Gastrointestinal Resections NCT06222645NA3 sites๐Ÿ“ Yantai๐Ÿ“ Saint Petersburg๐Ÿ“ Saint Petersburg Saint Petersburg State University, Russia ยท Tests: ICG fluorescence imaging technology, Imaging Photoplethysmography System A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer NCT07224750n/a1 site๐Ÿ“ Duarte City of Hope Medical Center Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC NCT04342910Phase 31 site๐Ÿ“ Beijing Jiangsu HengRui Medicine Co., Ltd. ยท Tests: camrelizumab, Apatinib Mesylate, Paclitaxel, Irinotecan Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore NCT06157996Phase 21 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: lenvatinib and tislelizumab plus CapeOX chemotherapy, tislelizumab plus CapeOX chemotherapy Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal Cancer NCT07166263EARLY Phase 11 site๐Ÿ“ Nanjing Base Therapeutics (Shanghai) Co., Ltd. ยท Tests: NK510, NK510 SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors NCT07812805Phase 15 sites๐Ÿ“ Glen Burnie๐Ÿ“ Pittsburgh๐Ÿ“ Seoul SK Life Science, Inc. ยท Tests: SKL35501, SKL35502 Multimodal Prehabilitation in Gastric Cancer Patients NCT07839702NA1 site๐Ÿ“ Singapore National University Hospital, Singapore ยท Tests: prehabilitation XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC NCT06742411Phase 1, Phase 22 sites๐Ÿ“ Chengdu๐Ÿ“ Chengdu West China Hospital ยท Tests: XELOX+Sintilimab+HBOT
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy